1. Home
  2. MTSR
  3. MTSR News

Latest METSERA INC (MTSR) News on July 27, 2025

Wall Street Analysts See an 89.66% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High?
MTSR

Zacks

a month ago

Wall Street Analysts See an 89.66% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High?

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i’s Positive Phase 1 Results
MTSR

Insider Monkey

a month ago

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i’s Positive Phase 1 Results

Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference
MTSR

GlobeNewswire

2 months ago

Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump
MTSR

Investor's Business Daily

2 months ago

Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump

MTSR

MT Newswires

2 months ago

Metsera's Phase 1 Trial of MET-233i Shows Weight Reduction With no Severe Adverse Events

Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch
MTSR

Investor's Business Daily

2 months ago

Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch

Metsera shares climb on early data for amylin-targeting obesity shot
MTSR

BioPharma Dive

2 months ago

Metsera shares climb on early data for amylin-targeting obesity shot

Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i
MTSR

GlobeNewswire

2 months ago

Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i

Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®
MTSR

GlobeNewswire

2 months ago

Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®

MTSR

MT Newswires

2 months ago

Metsera's Q1 Net Loss Narrows

Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress
MTSR

GlobeNewswire

2 months ago

Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress

Metsera to Present at Bank of America 2025 Global Healthcare Conference
MTSR

GlobeNewswire

3 months ago

Metsera to Present at Bank of America 2025 Global Healthcare Conference

MTSR

MT Newswires

4 months ago

Metsera's Q4 Net Loss Widens, Operating Expenses Rise; Shares Higher

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress
MTSR

GlobeNewswire

4 months ago

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress

Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month
MTSR

Insider Monkey

4 months ago

Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month

Is Metsera, Inc. (MTSR) Among Stocks With At Least $20 Million In Insider Spending Recently?
MTSR

Insider Monkey

5 months ago

Is Metsera, Inc. (MTSR) Among Stocks With At Least $20 Million In Insider Spending Recently?

Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending Recently
MTSR

Insider Monkey

5 months ago

Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending Recently

MTSR

Thomson Reuters StreetEvents

5 months ago

Q4 2024 Amneal Pharmaceuticals Inc Earnings Call

Metsera to Present at TD Cowen’s 45th Annual Health Care Conference
MTSR

GlobeNewswire

5 months ago

Metsera to Present at TD Cowen’s 45th Annual Health Care Conference

MTSR

Investing.com

5 months ago

Wall Street bullish on Metsera following January IPO on obesity drug pipeline

Metsera (MTSR): Among Stocks Insiders Spent The Most Money On Recently
MTSR

Insider Monkey

5 months ago

Metsera (MTSR): Among Stocks Insiders Spent The Most Money On Recently

MTSR

MT Newswires

6 months ago

Metsera Closes Initial Public Offering

MTSR

GlobeNewswire

6 months ago

Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares

MTSR

MT Newswires

6 months ago

Metsera Insider Bought Shares Worth $14,219,964, According to a Recent SEC Filing

MTSR

MT Newswires

6 months ago

Metsera Insider Bought Shares Worth $39,999,996, According to a Recent SEC Filing

MTSR

MT Newswires

6 months ago

Metsera Shares Rise Sharply in Nasdaq Debut

MTSR

MT Newswires

6 months ago

Metsera Prices $275 Million IPO

Drugmakers Metsera and Maze Raise Combined $415 Million in IPOs
MTSR

Bloomberg

6 months ago

Drugmakers Metsera and Maze Raise Combined $415 Million in IPOs

MTSR

GlobeNewswire

6 months ago

Metsera Announces Pricing of Initial Public Offering

Metsera, Maze secure combined $415 million in IPOs
MTSR

BioPharma Dive

6 months ago

Metsera, Maze secure combined $415 million in IPOs

Share on Social Networks: